BioXcel Therapeutics
BTAI
BTAI
11 hedge funds and large institutions have $9.35M invested in BioXcel Therapeutics in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$34K | |
| 2 | +$7.55K | |
| 3 | +$2.86K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$66 |
Top Sellers
| 1 | -$1.76M | |
| 2 | -$915K | |
| 3 | -$355K | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$146K |
| 5 |
Squarepoint
New York
|
-$142K |